Public Market Listing
BAYNXetra
Live quotes, historical charts, and market capitalization for Bayer are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(15 total)
15Total Assets
5Approved
5Phase 3 / Filed
5Phase 1–2 / Early
5Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
BAY2927088(Hyrnuo) | Approved | HER2 (ERBB2) exon 20 insertions and point mutations; also mutant-selective EGFRSmall molecule | Non-Small Cell Lung Cancer |
Finerenone(Kerendia) | Approved | Mineralocorticoid receptorSmall molecule | Heart FailureChronic Kidney Disease |
| Approved | Interferon beta receptor (type I IFN signaling) · Type I interferon receptorBiologic (subtype unspecified) | Multiple Sclerosis | |
| Approved | TRK (TRKA/TRKB/TRKC, encoded by NTRK1/NTRK2/NTRK3 gene fusions)Small molecule | Non-Small Cell Lung Cancer | |
Vericiguat(Verquvo) | Approved | Soluble guanylate cyclaseSmall molecule | Heart Failure |
Iloprost(Ventavis) | Phase 3 | IP receptor (prostacyclin pathway)Small molecule | Hypertension |
MolidustatNo recent activity | Phase 3 | HIF prolyl hydroxylase (HIF-PH1/2/3)Small molecule | Chronic Kidney Disease |
| Phase 3 | Soluble guanylate cyclaseSmall molecule | Hypertension Pulmonary Hypertension | |
Riociguat(Adempas) | Phase 3 | Soluble guanylate cyclaseSmall molecule | Hypertension |
| Phase 3 | EGFR/HER2Small molecule | Non-Small Cell Lung Cancer | |
| Phase 2 | Protein inhibitor-1 (gene therapy)Gene therapy / editing | Heart Failure | |
| Phase 2 | Soluble guanylate cyclaseSmall molecule | HypertensionChronic Kidney Disease | |
| Phase 1/2 | PRMT5Small molecule | Non-Small Cell Lung Cancer | |
| Phase 1 | Diacylglycerol kinase zeta (DGKζ)Small molecule | Non-Small Cell Lung Cancer | |
| Phase 1 | CCR8Monoclonal antibody | Non-Small Cell Lung Cancer |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.